Role of Quality of Life in Men with Metastatic Hormone-Refractory Prostate Cancer: How Does Atrasentan Influence Quality of Life?
- 1 May 2006
- journal article
- review article
- Published by Elsevier in European Urology
- Vol. 49 (5) , 781-789
- https://doi.org/10.1016/j.eururo.2005.12.058
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- EAU Guidelines on Prostate CancerEuropean Urology, 2005
- Climacteric-Like Disorders in Prostate Cancer Patients Treated With LHRH AgonistsArchives of Andrology, 2005
- OSTEOPOROSIS AND OBESITY IN MEN RECEIVING HORMONE THERAPY FOR PROSTATE CANCERJournal of Urology, 2004
- Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate CancerNew England Journal of Medicine, 2004
- A population-based study of pain and quality of life during the year before death in men with prostate cancerBritish Journal of Cancer, 2004
- EORTC prostate cancer trials: what have we learnt?Critical Reviews in Oncology/Hematology, 2002
- The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinomaCancer, 2000
- Chemotherapy for advanced hormone refractory prostate cancerUrology, 1999
- Complications of advanced prostate cancerUrology, 1999
- Skeletal complications of malignancyCancer, 1997